Cargando…
Pros and cons of corticosteroid therapy for COVID-19 patients
In December 2019, an outbreak of severe pneumonia was reported in Wuhan, China. Later described as COVID-19 (coronavirus disease 2019), this infection caused by a virus from the Coronaviridae family (SARS-CoV-2) has spread globally. Effective therapies for this new disease are urgently needed. In th...
Autores principales: | Mattos-Silva, Paula, Felix, Nathane Santanna, Silva, Pedro Leme, Robba, Chiara, Battaglini, Denise, Pelosi, Paolo, Rocco, Patricia Rieken Macedo, Cruz, Fernanda Ferreira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351052/ https://www.ncbi.nlm.nih.gov/pubmed/32659271 http://dx.doi.org/10.1016/j.resp.2020.103492 |
Ejemplares similares
-
Mild hypothermia combined with dexmedetomidine reduced brain, lung, and kidney damage in experimental acute focal ischemic stroke
por: Battaglini, Denise, et al.
Publicado: (2022) -
Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2021) -
Prone positioning in COVID-19 ARDS: more pros than cons
por: Battaglini, Denise, et al.
Publicado: (2022) -
Fluid management strategies and their interaction with mechanical ventilation: from experimental studies to clinical practice
por: de Carvalho, Eduardo Butturini, et al.
Publicado: (2023) -
Brain–heart interaction after acute ischemic stroke
por: Battaglini, Denise, et al.
Publicado: (2020)